Assessment of nitric oxide metabolites concentration in type 1 diabetic patients;Ocena ste+ (Combining ogonek sign);Żenia metabolitow tlenku azotu u chorych z typem 1 cukrzycy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 100, Issue 2, 1998, Pages 139-144

  Wierusz Wysocka, Bogna ^a   Zozulińska, Dorota ^a   Kempa, Magdalena ^a,b   Skowroński, Marcin ^a   Murawska, Agnieszka ^a  

^a Szpital im Fr Raszei   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diabetes mellitus; Late complications of diabetes; Nitric oxide

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NITRIC OXIDE;

EID: 0032130186     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Diabetes Control and Complications Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New. Engl. J. Med., 1993, 329, 977.
2. Brownlee M.: Glycation and diabeetic complication. Diabetes Care, 1994, 43, 836.
3. Ido Y., Kilo C., Williamson J.R.: Interaction between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction. Nephrol. Dial. Transplant., 1996, 11 (Suppl 5), 72.
4. Baynes J.W.: Role of oxidative stress in development of complications in diabetes. Diabetes, 1991, 40, 405.
5. Guigliano D , Ceriello A., Poalisso G.: Oxidative stress and diabetic vascular complications. Diabetes Care, 1996, 19, 257.
6. Cohen R.A.: The role of nitric oxide and other endothelium-derivated vasoactive substances in vascular disease. Prog Cardiovasc. Dis., 1995, 38, 105.
7. Munzel T., Heitzer T., Harrison D.G.: The physiology and pathophysiology of the nitric oxide/superoxide system. Herz, 1997, 22, 158.
8. Gilham M.B., Sherman M.P., Griscavag J.M. i wsp.: The spectrophotometric assay for nitrate using NADPH oxidation by aspergillus nitrate reductase. Anal. Biochem., 1993, 212, 359.
9. Stehouwer C.D.A., Fischer H.R.A., van Kuijk A.W.R., Polak B.C.P., Danker A.J.M.: Endothelial dysfunction precedes devolopment of microalbuminuria in IDDM. Diabetes, 1995, 44, 561.
10. Morise T., Takeuchi Y., Kawano M., Koni I., Takeda R.: Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care, 1995, 18, 87.
11. Tooke J.E , Sanderman D.D., Shore A.C.: Microvascular haemodynamics in hypertension and diabetes. J. Cardiovasc. Pharmacol., 1991, 18, 51
12. Johnstone M.T., Creager S J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A.: Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation, 1993, 88, 2510.
13. Sorbievu L., Mann G.E.: Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp. Physiol., 1997, 82, 423.
14. Steinberg H.O., Baron A.D.: Insulin-dependent diabetes mellitus and nitrovasodilatation. Important and complex interaction. Circulation, 1997, 95, 560.
15. Rabini R.A., Staffolani R., Fumelli P., Mutus B., Curatola G., Mazzanti L.: Decreased nitric synthase activity in platelets form IDDM and NIDDM patients. Diabetologia, 1998, 41, 101.
16. Cohen R.A.: Dysfunction of vascular endothelium in diabetes mellitus. Circulation, 1993, 87, V97.
17. Tesfamariam B.: Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol. Med., 1994, 16, 383.
18. Yagihashi N., Nishida N., Geuk Seo H., Tanaguchi N., Yagihashi S.: Expression of nitric oxide synthase in macula densa in streptozotocin diabetes rats. Diabetologia, 1996, 39, 793.
19. Trachtman H., Futterweit S., Crimmins D.L.: High glucose inhibits nitric oxide production in cultured rat mesangial cells. J. Am. Soc. Nephrol., 1997, 8, 1276.
20. Williams S.B., Cusco J.A , Roddy M.A., Johnstone M.T., Creager M.A.: Impaired nitric oxide mediated vasodilatation in patients with non-insulin dependent diabetes mellitus. J. Am. Coll. Cardiol., 1996, 27, 567.
21. Goor Y., Peer G., Iaina A.A. i wsp.: Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia, 1996, 39, 1036.
22. + and nitric oxide synthase in human endithelial cells: association with membrane hyperpolarization. J. Physiol., 1995, 489, 183.
23. Tilton R.G., Chang K., Hasan K.S. i wsp.: Prevention of diabetic vascular dysfunction by guanides: Inhibition of nitric oxide synthase versus advenced glycation end product formation. Diabetes, 1993, 42, 221.
24. Urakaze M., Temaru R., Satou A , Yamazaki K., Hamazaki T., kabayaski M.: The IL-8 production in endothelial cells is stimulated by high glucose. Horm. Metab. Res., 1996, 28, 400.
25. Zozulińska D., Majchrzak A., Sobieska M., Wiktorowicz K., Wierusz-Wysocka B.: Serum interleukin-8 is increased in diabetic patients. Diabetologia 1998, (w druku).
26. -) and HbA1c level in diabetic patients. Diabetes Res. Clin. Pract., 1993, 2, 109.
27. Majchrzak M., Kempa M., Zozulińska D., Wierusz-Wsocka B.: Antioxidative systems in well metabolically controlled type 1 diabetic patients. Diabetologia, 1998, 41 (suppl. 1), A321.
28. Mäkimattila S., Mäntysaari M , Groop P. i wsp.: Hyperreactivity to nitrovasodilatators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation, 1997, 95, 618.
29. Baron A.D.: Hemodynamic actions of insulin. Am. J. Physiol., 1994, 267, F187.